Search

everythinglearnresearchcommunity

for

Search:↓

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

The compound zishenqing formula is effective and safe for treating mild to moderate systemic lupus erythematosus.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Abrocitinib may effectively treat stubborn alopecia universalis.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

Exosomes from Pinctada martensii mucus can safely reduce melanin production, offering a new treatment for skin pigment issues.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Two women experienced temporary hair loss and other side effects from imiquimod treatment for cervical issues, which stopped after ending the treatment.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.